搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xanthomonas axonopodis pv. citri Methylthioribose-1-phosphate isomerase (mtnA) CSB-YP840150XAD
CSB-EP840150XAD
CSB-BP840150XAD
CSB-MP840150XAD
CSB-EP840150XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Kynureninase (kynU) CSB-YP840151XAD
CSB-EP840151XAD
CSB-BP840151XAD
CSB-MP840151XAD
CSB-EP840151XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Protein grpE (grpE) CSB-YP840152XAD
CSB-EP840152XAD
CSB-BP840152XAD
CSB-MP840152XAD
CSB-EP840152XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP840153XAD
CSB-EP840153XAD
CSB-BP840153XAD
CSB-MP840153XAD
CSB-EP840153XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP840154XAD
CSB-EP840154XAD
CSB-BP840154XAD
CSB-MP840154XAD
CSB-EP840154XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri GTPase Era (era) CSB-YP840155XAD
CSB-EP840155XAD
CSB-BP840155XAD
CSB-MP840155XAD
CSB-EP840155XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Ribosome maturation factor RimM (rimM) CSB-YP840156XAD
CSB-EP840156XAD
CSB-BP840156XAD
CSB-MP840156XAD
CSB-EP840156XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Putative arginyl-tRNA--protein transferase (ate) CSB-YP840157XAD
CSB-EP840157XAD
CSB-BP840157XAD
CSB-MP840157XAD
CSB-EP840157XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri 50S ribosomal protein L32 (rpmF) CSB-YP840158XAD
CSB-EP840158XAD
CSB-BP840158XAD
CSB-MP840158XAD
CSB-EP840158XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri 50S ribosomal protein L18 (rplR) CSB-YP840159XAD
CSB-EP840159XAD
CSB-BP840159XAD
CSB-MP840159XAD
CSB-EP840159XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri 50S ribosomal protein L24 (rplX) CSB-YP840160XAD
CSB-EP840160XAD
CSB-BP840160XAD
CSB-MP840160XAD
CSB-EP840160XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri 50S ribosomal protein L23 (rplW) CSB-YP840161XAD
CSB-EP840161XAD
CSB-BP840161XAD
CSB-MP840161XAD
CSB-EP840161XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Elongation factor G (fusA), partial CSB-YP840162XAD
CSB-EP840162XAD
CSB-BP840162XAD
CSB-MP840162XAD
CSB-EP840162XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Peptide chain release factor 1 (prfA) CSB-YP840163XAD
CSB-EP840163XAD
CSB-BP840163XAD
CSB-MP840163XAD
CSB-EP840163XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Ribosomal RNA large subunit methyltransferase M (rlmM) CSB-YP840164XAD
CSB-EP840164XAD
CSB-BP840164XAD
CSB-MP840164XAD
CSB-EP840164XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Protein ApaG (apaG) CSB-YP840165XAD
CSB-EP840165XAD
CSB-BP840165XAD
CSB-MP840165XAD
CSB-EP840165XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri tRNA-dihydrouridine synthase B (dusB) CSB-YP840166XAD
CSB-EP840166XAD
CSB-BP840166XAD
CSB-MP840166XAD
CSB-EP840166XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri Protein translocase subunit SecA (secA), partial CSB-YP840167XAD
CSB-EP840167XAD
CSB-BP840167XAD
CSB-MP840167XAD
CSB-EP840167XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG) CSB-YP840168XAD
CSB-EP840168XAD
CSB-BP840168XAD
CSB-MP840168XAD
CSB-EP840168XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas axonopodis pv. citri UPF0102 protein XAC0764 (XAC0764) CSB-YP840169XAD
CSB-EP840169XAD
CSB-BP840169XAD
CSB-MP840169XAD
CSB-EP840169XAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>